Palisade Bio develops oral drug candidates for inflammatory bowel disease, led by PALI-2108 for ulcerative colitis and Crohn's disease. It last closed at $0.84 on Nov 20, down 9.24% on the day. The next earnings report for PALI is expected around Tue, Feb 9, 2027, after the close. For the quarter ended Sep 2026, PALI reported EPS of -$0.07 on revenue of $0. Over its last 5 reports the stock moved an average of 3.1% the session after earnings. Over the last 12 months PALI insiders bought $347K of stock on the open market and sold $420K, according to SEC Form 4 filings.
AI Auto Pilots
Is PALI in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold PALI.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on PALIStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
PALI · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 33% below its 20 day and 63% below its 50 day average. It is 115% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 25), oversold. The nearest support is the Pivot S1 at $0.80, and the nearest resistance the 52 week low at $0.84.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 11.2%/day
Key levels
$2.8552 week high+239.3%
$1.81200 day average+115.5%
$1.70100 day average+102.4%
$1.3750 day average+63.1%
$1.30Swing high (Nov 4)+54.8%
$1.1220 day average+33.3%
$0.92Pivot R1+9.5%
$0.88Pivot+4.8%
$0.8452 week low+0.0%
$0.84Last close
$0.80Pivot S1−4.8%
Indicators
RSI (14)
24.56
Oversold below 30
Oversold
MACD
-0.13
Below its signal line
Bearish
Stochastic
1.0
Near the bottom of its range
Oversold
ADX (14)
43.6
Strong downtrend
Williams %R
-99.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-208.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−25.7%
Change over 10 sessions
Bearish
ATR (14)
$0.09
Typical daily range, 11.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 31.8%/day
Key levels
$2.8552 week high+239.3%
$1.81200 day average+115.5%
$1.70100 day average+102.4%
$1.3750 day average+63.1%
$1.30Swing high (Nov 4)+54.8%
$1.1220 day average+33.3%
$0.92Pivot R1+9.5%
$0.88Pivot+4.8%
$0.8452 week low+0.0%
$0.84Last close
$0.80Pivot S1−4.8%
Indicators
RSI (14)
27.77
Oversold below 30
Oversold
MACD
-0.22
Below its signal line
Bearish
Stochastic
2.6
Near the bottom of its range
Oversold
ADX (14)
23.4
Weak trend
Williams %R
-99.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-146.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−59.2%
Change over 10 sessions
Bearish
ATR (14)
$0.27
Typical daily range, 31.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for PALI
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how PALI did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow PALI usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for PALIHow many large options trades hit PALI, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in PALI in the last 90 days.
From SEC Form 4 filings by PALI's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether PALI is in one of them and how their past PALI trades turned out.
Palisade Bio is a biopharmaceutical company based in Carlsbad, California, that is developing oral medicines for inflammatory bowel disease. Its lead candidate, PALI-2108, is a pill taken once a day that stays inactive until it reaches the lower intestine, where gut bacteria convert it into an active drug at sites of inflammation. The company is testing the candidate in people with ulcerative colitis and Crohn's disease. Its candidates are still in clinical testing and are not yet on the market.